Anti-Mouse CD309 (FLK1) PE 200 ug
- Known as:
- Antibody toMouse CD309 (FLK1) PE 200 ug
- Catalog number:
- 12-5821-83
- Category:
- -
- Supplier:
- eBioscience
- Gene target:
- Anti-Mouse CD309 (FLK1) 200
Related genes to: Anti-Mouse CD309 (FLK1) PE 200 ug
- Gene:
- KDR NIH gene
- Name:
- kinase insert domain receptor
- Previous symbol:
- -
- Synonyms:
- FLK1, VEGFR, VEGFR2, CD309
- Chromosome:
- 4q12
- Locus Type:
- gene with protein product
- Date approved:
- 1991-07-10
- Date modifiied:
- 2019-04-23
Related products to: Anti-Mouse CD309 (FLK1) PE 200 ug
Related articles to: Anti-Mouse CD309 (FLK1) PE 200 ug
- The rapid spread of insecticide resistance threatens the effectiveness of malaria vector control across sub-Saharan Africa. In southern Benin, the respective contributions of agricultural pesticide use and urban vector control interventions to the selection of resistant Anopheles populations remain poorly documented. - Source: PubMed
Publication date: 2026/09/20
Boko Mahuna PierreTokponnon FilémonAhouandjinou Minassou JuvénalDiloma Soma DieudonnéHougbe Steve ZinsouAffolabi Zul-KiflDabou Zoulkifilou SareFassinou Arsène JacquesSagbohan HermannTowakinou LindaVigninou EstelleHoundeton Cyrille SalvadorDayou Séchimè EliphèlethNamountougou MoussaOssé Razaki AAkogbéto Martin C - Aedes aegypti is a primary vector for major arboviruses such as dengue, Zika, and chikungunya, imposes a significant disease burden in tropical and subtropical regions. The widespread application of pyrethroid insecticides for vector control has led to the global dissemination of knockdown resistance (kdr) mutations, a major resistance mechanism. Continuous surveillance of kdr mutations is therefore essential to inform and optimize vector control strategies. To characterize the kdr profile, we first employed targeted capture sequencing on 12 individual mosquitoes from three field-derived strains collected in Taiwan in 2021. Subsequently, direct Sanger sequencing was performed on 99 mosquitoes field-collected in 2024. Furthermore, topical bioassay using a series of deltamethrin concentrations were conducted on 200 mosquitoes, followed by direct sequencing to link resistance phenotypes to specific genotypes. A characterized insecticide-susceptible strain (KHSM) served as a control. We identified a novel leucine to phenylalanine substitution at position 932 (L932F) in the voltage-gated sodium channel (VGSC) of Aedes aegypti in Taiwan. The emerging mutant was initially detected in a strain carrying the double kdr genotype (S989P and V1016G) and was subsequently detected in field population across Southern Taiwan, with its presence confirmed in archived samples dating from 2020-2022. The mutation was crucially associated with reduced susceptibility to deltamethrin in topical bioassays. This study provides the first report of the L932F kdr mutation in Ae. aegypti, indicating the emergence of a novel mutation in Taiwanese populations. Furthermore, the L932F mutation may contribute to reduced deltamethrin susceptibility, even in triple-mutant individuals co-harboring the well-established S989P and V1016G resistance alleles. - Source: PubMed
Publication date: 2026/09/20
Tsai I-JungChung Han-HsuanItokawa KentaroKomagata OsamuKasai ShinjiChen Shiu-Ling - Neurological manifestations of systemic sclerosis (SSc), including autonomic dysfunction and peripheral neuropathy, are clinically recognized, but their relationship to SSc tissue injury remains poorly defined. We integrated public SSc blood, PBMC, skin and single-cell transcriptomes with an external human peripheral nerve lesion reference to test whether neuroimmune programs are embedded in immune-vascular-fibrotic remodeling. Across four SSc cohorts, pathway analyses identified recurrent interferon activation and skin-enriched fibrosis/TGF-beta, vascular endothelial, chemokine, complement/phagocytosis, neuroimmune-core and peripheral nerve injury signatures. Rank-AUC, ssGSEA and same-size random gene-set analyses supported these findings, and 22 of 70 curated cohort-signature tests remained significant after global Benjamini-Hochberg correction. A 17-gene exploratory score retained moderate discrimination in independent whole blood (AUC = 0.759), but nested cross-validation and stability analyses supported its use as a molecular summary, not a clinical classifier. In GSE250152, 3972 genes were differentially expressed in human peripheral nerve lesions, and lesion-signature projection showed FDR-significant shifts in SSc skin. Single-cell analysis of 146,426 cells localized vascular, fibrotic, interferon, chemokine and selected neuroimmune signals mainly to fibroblast, endothelial, pericyte, T-cell and myeloid-associated skin compartments. Cell-type-frequency adjustment preserved the direction of all 15 highlighted compartment-signature effects, with seven remaining significant after global correction. Ligand-receptor analyses prioritized IL1B-IL1R1, TNF-TNFRSF1A, VEGFA-KDR and TGFB1-TGFBR1 as speculative expression-potential routes rather than demonstrated communication events. These data support a bounded model linking SSc-related neural vulnerability to an immune-vascular-fibrotic neuroimmune niche. Prospective neurologically phenotyped cohorts are required for clinical validation. - Source: PubMed
Publication date: 2026/09/18
Lu YangHe YingtongYao JiayingHuang ShuxuanChen WeiweiZheng Lifen - Conventional chemotherapeutic treatment of colorectal cancer causes adverse effects such as severe diarrhoea, mucositis and hepatotoxicity. This study aimed to investigate the anti-carcinogenic potential of epigallocatechin-3-gallate and its effects on major angiogenic markers, alone and in combination with irinotecan in colorectal cancer model. - Source: PubMed
Publication date: 2026/09/17
Rahman Sabana SargamBaruah SukanyaAkhtara NabilaNath Jaydeep KumarBharali Manuj Kumar - - Source: PubMed
Publication date: 2026/09/16
Wang YuhengWei XiaoluWang HuijunZhang YanLi PengyueZhou YawenJiang ShanRong YanChen LihuaZhao Haiyu